Patent 11485959 was granted and assigned to Poseida Therapeutics on November, 2022 by the United States Patent and Trademark Office.
The present invention provides PiggyBac transposase proteins, nucleic acids encoding the same, compositions comprising the same, kits comprising the same, non-human transgenic animals comprising the same, and methods of using the same.